PNC Financial Services Group Inc. Has $13.97 Million Holdings in Agilent Technologies Inc (NYSE:A)

PNC Financial Services Group Inc. grew its holdings in shares of Agilent Technologies Inc (NYSE:A) by 4.6% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 195,090 shares of the medical research company’s stock after purchasing an additional 8,654 shares during the period. PNC Financial Services Group Inc.’s holdings in Agilent Technologies were worth $13,973,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in A. NuWave Investment Management LLC grew its position in shares of Agilent Technologies by 1,116.1% during the 1st quarter. NuWave Investment Management LLC now owns 377 shares of the medical research company’s stock worth $27,000 after purchasing an additional 346 shares in the last quarter. First Bank & Trust acquired a new stake in shares of Agilent Technologies during the 4th quarter worth approximately $29,000. Citizens Financial Group Inc RI boosted its position in shares of Agilent Technologies by 260.0% during the 4th quarter. Citizens Financial Group Inc RI now owns 360 shares of the medical research company’s stock worth $31,000 after acquiring an additional 260 shares in the last quarter. FinTrust Capital Advisors LLC boosted its position in shares of Agilent Technologies by 450.7% during the 4th quarter. FinTrust Capital Advisors LLC now owns 380 shares of the medical research company’s stock worth $32,000 after acquiring an additional 311 shares in the last quarter. Finally, Sowa Financial Group Inc. boosted its position in shares of Agilent Technologies by 1,425.0% during the 1st quarter. Sowa Financial Group Inc. now owns 488 shares of the medical research company’s stock worth $35,000 after acquiring an additional 456 shares in the last quarter.

In related news, CEO Michael R. Mcmullen sold 18,018 shares of Agilent Technologies stock in a transaction on Friday, May 8th. The shares were sold at an average price of $80.00, for a total transaction of $1,441,440.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP Mark Doak sold 3,494 shares of Agilent Technologies stock in a transaction on Tuesday, March 3rd. The stock was sold at an average price of $83.81, for a total transaction of $292,832.14. Following the transaction, the vice president now directly owns 135,678 shares of the company’s stock, valued at approximately $11,371,173.18. The disclosure for this sale can be found here. Insiders have sold 43,929 shares of company stock valued at $3,476,727 in the last ninety days.

A has been the topic of several analyst reports. Barclays reduced their price target on shares of Agilent Technologies from $85.00 to $76.00 and set an “equal weight” rating on the stock in a research report on Thursday, March 26th. Cowen increased their price target on shares of Agilent Technologies from $80.00 to $95.00 and gave the stock an “outperform” rating in a research report on Friday. SVB Leerink increased their price target on shares of Agilent Technologies from $90.00 to $95.00 and gave the stock an “outperform” rating in a research report on Friday. UBS Group raised their target price on shares of Agilent Technologies from $84.00 to $87.00 and gave the company a “neutral” rating in a research report on Friday. Finally, Cfra cut their target price on shares of Agilent Technologies from $89.00 to $85.00 and set a “hold” rating on the stock in a research report on Friday. Eleven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Agilent Technologies presently has a consensus rating of “Hold” and an average target price of $85.75.

A stock opened at $84.98 on Friday. The company has a fifty day moving average price of $77.33 and a 200-day moving average price of $79.96. The company has a market capitalization of $25.00 billion, a P/E ratio of 25.47 and a beta of 1.10. Agilent Technologies Inc has a 52-week low of $61.13 and a 52-week high of $90.64. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.27 and a current ratio of 1.64.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Thursday, May 21st. The medical research company reported $0.71 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.61 by $0.10. The firm had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.20 billion. Agilent Technologies had a net margin of 13.04% and a return on equity of 20.75%. The company’s revenue for the quarter was up .2% on a year-over-year basis. During the same quarter last year, the firm earned $0.71 earnings per share. As a group, sell-side analysts forecast that Agilent Technologies Inc will post 2.95 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.85%. The ex-dividend date is Monday, June 29th. Agilent Technologies’s payout ratio is currently 23.15%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Recommended Story: What is the yield curve?

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.